Description
Tesamorelin is a synthetic 44-amino acid analogue of human growth hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoic acid modification at the N-terminus, which stabilizes the peptide against dipeptidyl peptidase IV (DPP-IV) cleavage and extends its functional half-life. It is supplied as a lyophilized powder for in vitro research applications involving GHRH receptor signalling, GH axis biology, and metabolic lipid pathway research.
Molecular Profile
CAS Number: 218949-48-5
Molecular Weight: 5,135.85 Da
Sequence Length: 44 amino acids + trans-3-hexenoic acid N-terminal modification
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water
Research Context
Tesamorelin is a well-characterized GHRH analogue with a substantial body of peer-reviewed preclinical and clinical research. In vitro applications include GHRH receptor binding affinity studies, pituitary somatotroph signalling research, cAMP production assays, and DPP-IV stability comparison studies against unmodified GHRH analogues. Its documented utility in visceral adipose tissue biology research — via GH axis-dependent lipid metabolism pathway modulation — makes it a relevant compound for metabolic signalling research teams.
This compound is available exclusively for in vitro laboratory research and scientific study conducted within Canada. It is not a drug, natural health product, or food product as defined under the Food and Drugs Act (R.S.C., 1985, c. F-27). It is not approved for human consumption, veterinary use, or any diagnostic or therapeutic application. This product has not been evaluated by Health Canada. Researchers are responsible for compliance with all applicable federal, provincial, and local regulations.





Big Tony –
Fast shipping fast response thanks guys!
Max –
Thanks. Got it right away
northernresearchsupply –
Thanks for ordering Max!